VRTX

HOLD

Vertex Pharmaceuticals Incorpor

Healthcare · Rank #17 · Analyzed Apr 20, 2026

$441.20

Current Price

$1202.69

Intrinsic Value

0.0%

Upside/Downside

10/10

Score

4.5/5

Quality

Analysis Summary

Valuation Consensus1/3 methods agree

Quality Score4.5/5.0

Framework RatingHOLD

Price vs Intrinsic ValueOvervalued by 0.0%

Fair Value Range

Low$58.71

Base (IV)$1202.69

High$1713.17

Entry Points

Conservative$58.71

Moderate$630.70

Aggressive$1202.69

⚠️ Warnings

Upside capped: raw 288% exceeds 200% — valuation unreliable

Quality & Moat Breakdown

Return on Equity22.5% → 1.0/1.0

Debt LevelD/E 11 → 1.0/1.0

Revenue QualityGrowth 7.9%, margin Δ+6.7% +recovery → 1.0/1.0

Moat Strength2.5/5 → 0.5/1.0

Profit Margins32.9% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.